Sign in
Taking people in NetherlandsPhase 1/2

Tests a PARP inhibitor with heated chemotherapy during surgery for ovarian cancer

Tests a PARP inhibitor with heated chemotherapy in adults with ovarian or fallopian tube cancer.

Key facts

Who runs it
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Where
Amsterdam and Utrecht, NetherlandsSee the 2 sites
Registry title
Exploiting the synergistic effect of PARP inhibition with cisplatin and hyperthermia during interval cytoreductive surgery and HIPEC in ovarian cancer: The PROOV study - A Phase I/II clinical trial
Status
Recruiting
Phase
Phase 1/2
People taking part
55 people, planned
Started
7 Apr 2025
Expected to end
1 May 2034
Type of study
Interventional
Record updated
2 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18 or older with ovarian, fallopian tube or extraovarian cancer who have surgery with heated chemotherapy inside the belly (HIPEC).

Age
18 Years or older
Sex
Women only
Disease stage
Ovarian cancer, fallopian tube cancer or extraovarian cancer.

Where in Netherlands

  • Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, NetherlandsTaking people
  • Universitair Medisch Centrum UtrechtUtrecht, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests a PARP inhibitor with heated chemotherapy during surgery for ovarian cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
2 October 2026